JK Agri Genetics to Sell Telangana Leasehold Rights for Rs 19.8 Crore

AGRICULTURE
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
JK Agri Genetics to Sell Telangana Leasehold Rights for Rs 19.8 Crore

JK Agri Genetics has approved the transfer of leasehold rights for 5.28 acres of non-operational land in Telangana to Sai Life Sciences Limited. The deal is valued at Rs 19.80 crore and is expected to close within one month, providing a boost to the company's cash flow and financial flexibility.

JK Agri Genetics Monetizes Non-Operational Land Asset for Rs 19.8 Crore

JK Agri Genetics to sell leasehold rights for Rs 19.80 crore to Sai Life Sciences Limited.
The transfer involves 5.28 acres of non-operational land located at IKP Knowledge Park, Telangana.

Reader Takeaway: Divestment unlocks capital from idle assets, providing an immediate liquidity boost to the company’s balance sheet.

What just happened

The Board of Directors of JK Agri Genetics has approved the transfer of its leasehold rights for an immovable property spanning 5.28 acres in Turkapally Village, Telangana. The buyer, Sai Life Sciences Limited, is a player in the CRDMO space. The transaction is valued at Rs 19.80 crore, payable via demand draft upon completion, which the company expects within the next 30 days.

Why this matters

This move serves as a tactical asset monetization strategy. By liquidating a non-operational asset, JK Agri Genetics aims to optimize its financial resources and improve cash flow. The company has clarified that this transaction does not involve the promoter group and is not classified as a related party transaction, ensuring standard governance compliance.

Governance and Compliance

The company confirmed that this sale does not trigger provisions under Section 180(1)(a) of the Companies Act, 2013, as the asset does not represent substantially the whole of the undertaking. Consequently, no specific scheme of arrangement or special regulatory hurdles are associated with the divestment.

What to track next

Investors should monitor the formal completion of the transfer within the one-month window and watch for management commentary on the deployment of these proceeds in upcoming quarterly results.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.